Description

GenRx KPV (Lysine–Proline–Valine) is a synthetic tripeptide derived from the C-terminal sequence of the α-melanocyte-stimulating hormone (α-MSH). This research compound has gained significant interest in scientific studies for its potential roles in modulating inflammatory pathways and supporting epithelial integrity in various in-vitro and in-vivo models.

Key Features:

• Molecular Formula: C₁₉H₃₂N₆O₅
• Molecular Weight: 424.49 g/mol
• Form: Lyophilized (freeze-dried) powder
• Purity: ≥ 99% (by HPLC)
• Storage: Store in a cool, dry environment away from direct light; reconstituted material should be refrigerated (2–8 °C)
• Packaging: Sealed 10 mg vial for laboratory use

Research Applications:
Investigated for its anti-inflammatory, cytoprotective, and epithelial-stabilizing properties across various experimental models. KPV may play a role in modulating cellular signaling involved in inflammation and immune response, making it of interest for ongoing peptide-based research.

Intended Use:
For laboratory research purposes only. Not for human or animal consumption, injection, or diagnostic procedures. Researchers should adhere to appropriate safety and handling protocols.